instruction
stringlengths 4
15.8k
| input
stringclasses 1
value | output
stringlengths 1
5.09k
| text
stringlengths 152
16.1k
|
---|---|---|---|
What is the current status of nicotine addiction therapy?
|
The past, present, and future
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the current status of nicotine addiction therapy?. ### Response: The past, present, and future.
|
|
What is a final recommendation statement of the US Preventive Services Task Force?
|
Tobacco Smoking Cessation in Adults
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a final recommendation statement of the US Preventive Services Task Force?. ### Response: Tobacco Smoking Cessation in Adults.
|
|
In what year was the Cochrane Database Syst Rev published?
|
2012
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: In what year was the Cochrane Database Syst Rev published?. ### Response: 2012.
|
|
S4.5-23. US Preventive Services Task Force. Final Recommendation Statement: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions.
|
Interventions for smoking cessation in hospitalised patients
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: S4.5-23. US Preventive Services Task Force. Final Recommendation Statement: Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions.. ### Response: Interventions for smoking cessation in hospitalised patients.
|
|
What is the name of the TIMI 9A Investigators?
|
Antman
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the TIMI 9A Investigators?. ### Response: Antman.
|
|
What was the safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial?
|
Hirudin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A trial?. ### Response: Hirudin.
|
|
How long did it take for Hirudin to be used in acute myocardial infarction?
|
1624 - 1630
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How long did it take for Hirudin to be used in acute myocardial infarction?. ### Response: 1624 - 1630.
|
|
What is the name of the Thrombolysis and Thrombin Inhibition in Myocardia 9B trial?
|
Circulation
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the Thrombolysis and Thrombin Inhibition in Myocardia 9B trial?. ### Response: Circulation.
|
|
What is the name of the randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes?
|
GUSTO IIA Investigators
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes?. ### Response: GUSTO IIA Investigators.
|
|
What is GUSTO IIa?
|
Global Use of Strategies to Open Occluded Coronary Arteries
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is GUSTO IIa?. ### Response: Global Use of Strategies to Open Occluded Coronary Arteries.
|
|
How many investigators were there in 1994?
|
61
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How many investigators were there in 1994?. ### Response: 61.
|
|
What was the total number of investigators?
|
956 - 961
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was the total number of investigators?. ### Response: 956 - 961.
|
|
What is a comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes?
|
Randomized trial
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes?. ### Response: Randomized trial.
|
|
What is the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO)?
|
IIb investigators
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO)?. ### Response: IIb investigators.
|
|
How many ( 11 ): 775 - 782?
|
335
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How many ( 11 ): 775 - 782?. ### Response: 335.
|
|
What is used in high-risk coronary angioplasty?
|
monoclonal antibody
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is used in high-risk coronary angioplasty?. ### Response: monoclonal antibody.
|
|
The EPIC Investigation uses what antibody?
|
monoclonal
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: The EPIC Investigation uses what antibody?. ### Response: monoclonal.
|
|
What is the name of the study that investigated platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization?
|
EPILOG Investigators
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the study that investigated platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization?. ### Response: EPILOG Investigators.
|
|
Low-dose heparin during percutaneous coronary revascularization?
|
Platelet glycoprotein IIb/IIIa receptor blockade
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Low-dose heparin during percutaneous coronary revascularization?. ### Response: Platelet glycoprotein IIb/IIIa receptor blockade.
|
|
N Engl J Med. 1997; 336 ( 24): 1689 - 1696.
|
1689 - 1696
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: N Engl J Med. 1997; 336 ( 24): 1689 - 1696.. ### Response: 1689 - 1696.
|
|
Landefeld CS, Cook EF, et al.
|
Cook EF
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Landefeld CS, Cook EF, et al.. ### Response: Cook EF.
|
|
What is a predictor of major bleeding in hospitalized patients starting anticoagu-lant therapy?
|
preliminary validation
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a predictor of major bleeding in hospitalized patients starting anticoagu-lant therapy?. ### Response: preliminary validation.
|
|
Who started anticoagu-lant therapy in 1987?
|
hospitalized patients
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Who started anticoagu-lant therapy in 1987?. ### Response: hospitalized patients.
|
|
What is the name of the journal that published 82 ( 4 ): 703-713?
|
N Engl J Med
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the name of the journal that published 82 ( 4 ): 703-713?. ### Response: N Engl J Med.
|
|
What is a bleeding risk index for?
|
estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a bleeding risk index for?. ### Response: estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy.
|
|
What is an amjmed index for estimating the probability of major bleeding?
|
bleeding risk index
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is an amjmed index for estimating the probability of major bleeding?. ### Response: bleeding risk index.
|
|
What is the weight-based heparin nomogram?
|
practice guideline
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the weight-based heparin nomogram?. ### Response: practice guideline.
|
|
What is a practice guideline?
|
weight-based heparin nomogram
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a practice guideline?. ### Response: weight-based heparin nomogram.
|
|
What is weight-based heparin nomogram as a practice guideline?
|
The effectiveness
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is weight-based heparin nomogram as a practice guideline?. ### Response: The effectiveness.
|
|
How many ( 15 ): 1645 - 1649?
|
156
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How many ( 15 ): 1645 - 1649?. ### Response: 156.
|
|
What is a prospective study of the value of monitoring heparin treatment with the activated par-tial thromboplastin time?
|
N Engl J Med
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a prospective study of the value of monitoring heparin treatment with the activated par-tial thromboplastin time?. ### Response: N Engl J Med.
|
|
Med. 1972 ; 287 ( 7 ): 324 - 327.
|
N Engl J Med
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Med. 1972 ; 287 ( 7 ): 324 - 327.. ### Response: N Engl J Med.
|
|
Bain B, Forster T, Sleigh B. What is the difference between the activated partial thromboplastin time and hisparin?
|
Heparin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Bain B, Forster T, Sleigh B. What is the difference between the activated partial thromboplastin time and hisparin?. ### Response: Heparin.
|
|
What is the difference between heparin and the activated partial thromboplastin time?
|
—
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the difference between heparin and the activated partial thromboplastin time?. ### Response: —.
|
|
What was Kimberly Henricks on February 10, 2012?
|
American College of Chest Physicians
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What was Kimberly Henricks on February 10, 2012?. ### Response: American College of Chest Physicians.
|
|
What is the 2020 ACC/AHA Guideline for the Management of Valvular Heart Disease?
|
Otto et al 2020 ACC/AHA Guideline for the Management of Valvular Heart DiseaseFebruary 2, 2021 Circulation. 2021;143:e72–e227
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the 2020 ACC/AHA Guideline for the Management of Valvular Heart Disease?. ### Response: Otto et al 2020 ACC/AHA Guideline for the Management of Valvular Heart DiseaseFebruary 2, 2021 Circulation. 2021;143:e72–e227.
|
|
What is a recommendation for Timing of Intervention for Mixed AS and AR?
|
AVR
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a recommendation for Timing of Intervention for Mixed AS and AR?. ### Response: AVR.
|
|
What does Online Data Supplement 33.COR LOE Recommendations1 B-NR1 summarize?
|
studies that support the recommendations
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What does Online Data Supplement 33.COR LOE Recommendations1 B-NR1 summarize?. ### Response: studies that support the recommendations.
|
|
In symptomatic patients with combined AS and AR, what is the peak transvalvular jet velocity of at least 4.0 m/s?
|
AVR is recommended
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: In symptomatic patients with combined AS and AR, what is the peak transvalvular jet velocity of at least 4.0 m/s?. ### Response: AVR is recommended.
|
|
What is the mean transvalvular gradient of at least 40 mm Hg?
|
AVR
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the mean transvalvular gradient of at least 40 mm Hg?. ### Response: AVR.
|
|
What is SAVR recommended for in asymptomatic patients with combined AS and AR?
|
jet velocity of ≥4.0 m/s with an LVEF <50%,
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is SAVR recommended for in asymptomatic patients with combined AS and AR?. ### Response: jet velocity of ≥4.0 m/s with an LVEF <50%,.
|
|
What is the peak transvalvular jet velocity of 4.0 m/s?
|
≥
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the peak transvalvular jet velocity of 4.0 m/s?. ### Response: ≥.
|
|
Isolated moderate AS or moderate AR is currently placed in what stage?
|
Stage B
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Isolated moderate AS or moderate AR is currently placed in what stage?. ### Response: Stage B.
|
|
What is Stage B progressive disease for which no therapeutic action is indicated?
|
isolated moderate AS or moderate AR
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is Stage B progressive disease for which no therapeutic action is indicated?. ### Response: isolated moderate AS or moderate AR.
|
|
Some patients with moderate mixed disease develop symptoms that stem from their valve disease?
|
LV dysfunction, as evidenced by an LVEF of <50%, and who have no other reason for LV dysfunction
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Some patients with moderate mixed disease develop symptoms that stem from their valve disease?. ### Response: LV dysfunction, as evidenced by an LVEF of <50%, and who have no other reason for LV dysfunction.
|
|
What argument was raised that if there was no AR, the aortic jet velocity and gradient would be what?
|
correspondingly lower
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What argument was raised that if there was no AR, the aortic jet velocity and gradient would be what?. ### Response: correspondingly lower.
|
|
What would not meet the definitions for severe AS?
|
aortic jet velocity and gradient
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What would not meet the definitions for severe AS?. ### Response: aortic jet velocity and gradient.
|
|
What would be only moderate AR by defi-nition?
|
aortic jet velocity and gradient would be correspondingly lower and would not meet the definitions for severe AS
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What would be only moderate AR by defi-nition?. ### Response: aortic jet velocity and gradient would be correspondingly lower and would not meet the definitions for severe AS.
|
|
Recent data suggest that the natural his-tory of moderate mixed disease behaves similarly to that of pure disease?
|
valve disease
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Recent data suggest that the natural his-tory of moderate mixed disease behaves similarly to that of pure disease?. ### Response: valve disease.
|
|
How does moderate mixed disease compare to pure severe AS1?
|
similarly
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How does moderate mixed disease compare to pure severe AS1?. ### Response: similarly.
|
|
What is a similar mortality risk to that of pure severe ass?
|
moderate mixed disease
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a similar mortality risk to that of pure severe ass?. ### Response: moderate mixed disease.
|
|
How is valve replacement war -ranted for the symptomatic patient if the patient's data meet criteria for severe AS?
|
AVR is recommended
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How is valve replacement war -ranted for the symptomatic patient if the patient's data meet criteria for severe AS?. ### Response: AVR is recommended.
|
|
What criteria does TAVI ver -sus SAVR meet for severe AS?
|
any of the criteria
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What criteria does TAVI ver -sus SAVR meet for severe AS?. ### Response: any of the criteria.
|
|
What is discussed in Section 3.2.4.2.2?
|
The decision about whether to proceed with TAVI ver -sus SAVR
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is discussed in Section 3.2.4.2.2?. ### Response: The decision about whether to proceed with TAVI ver -sus SAVR.
|
|
What is presumed to be the cause of LV dysfunction?
|
valve disease
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is presumed to be the cause of LV dysfunction?. ### Response: valve disease.
|
|
What is indicated in mixed AS and MRPatients with combined AS and MR?
|
AVR
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is indicated in mixed AS and MRPatients with combined AS and MR?. ### Response: AVR.
|
|
What kind of decision-making process is involved in an in-dividual patient?
|
shared decision-making with the patient
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What kind of decision-making process is involved in an in-dividual patient?. ### Response: shared decision-making with the patient.
|
|
What type of AS and primary MR patients are best treated with?
|
combined
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What type of AS and primary MR patients are best treated with?. ### Response: combined.
|
|
Who makes the decisions for in-diviual patients?
|
an MDT
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Who makes the decisions for in-diviual patients?. ### Response: an MDT.
|
|
What are patients with severe AS and severe primary MR best treated with?
|
SAVR and mitral valve surgery
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are patients with severe AS and severe primary MR best treated with?. ### Response: SAVR and mitral valve surgery.
|
|
What is best treated unless the surgical risk is high or prohibitive?
|
patients with severe AS and severe primary MR
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is best treated unless the surgical risk is high or prohibitive?. ### Response: patients with severe AS and severe primary MR.
|
|
A staged procedure with TAVI followed by mitral TEER can be effective if there is severe what?
|
high or prohibitive surgical risk
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: A staged procedure with TAVI followed by mitral TEER can be effective if there is severe what?. ### Response: high or prohibitive surgical risk.
|
|
What can be effective if there is severe AS and severe secondary MR?
|
SAVR and mitral valve surgery
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What can be effective if there is severe AS and severe secondary MR?. ### Response: SAVR and mitral valve surgery.
|
|
What is Hb A1c?
|
glycosylat ed haemoglobin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is Hb A1c?. ### Response: glycosylat ed haemoglobin.
|
|
What is peak flo w or spir ometr y?
|
urinalysis
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is peak flo w or spir ometr y?. ### Response: urinalysis.
|
|
What should you do when a diagnosis of hear t failure has been made?
|
assess se verity, aetiology , precipitating f actors, type of car diac dysfunction and correctable causes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What should you do when a diagnosis of hear t failure has been made?. ### Response: assess se verity, aetiology , precipitating f actors, type of car diac dysfunction and correctable causes.
|
|
What is aetiology, precipitating f actors, type of car diac dysfunction and correctable causes of heart failure?
|
assess se verity
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is aetiology, precipitating f actors, type of car diac dysfunction and correctable causes of heart failure?. ### Response: assess se verity.
|
|
What is heart failure caused by?
|
valve dise
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is heart failure caused by?. ### Response: valve dise.
|
|
What is the NICE guideline on hear t valve disease?
|
1.2.14 When a diagnosis of hear t failure has been made, assess se verity, aetiology , precipitating f actors, type of car diac dysfunction and correctable causes. [2010] Heart failur e caused by valve dise ase 1.2.15 Refer people wit h hear t failure caused b y valve disease f or specialist assessment and advice r egar ding f ollow-up. See t he section on r eferral for echocar diograph y and specialist assessment
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the NICE guideline on hear t valve disease?. ### Response: 1.2.14 When a diagnosis of hear t failure has been made, assess se verity, aetiology , precipitating f actors, type of car diac dysfunction and correctable causes. [2010] Heart failur e caused by valve dise ase 1.2.15 Refer people wit h hear t failure caused b y valve disease f or specialist assessment and advice r egar ding f ollow-up. See t he section on r eferral for echocar diograph y and specialist assessment.
|
|
What is t he basis f or a hist orical diagnosis of?
|
hear t failure
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is t he basis f or a hist orical diagnosis of?. ### Response: hear t failure.
|
|
What is a basis for a hist orical diagnosis of hear t failure?
|
assess se verity, aetiology , precipitating f actors, type of car diac dysfunction and correctable causes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a basis for a hist orical diagnosis of hear t failure?. ### Response: assess se verity, aetiology , precipitating f actors, type of car diac dysfunction and correctable causes.
|
|
How can you manage care in accor dance with this guideline only if the diagnosis is confirmed?
|
Review t he basis f or a hist orical diagnosis of hear t failure
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: How can you manage care in accor dance with this guideline only if the diagnosis is confirmed?. ### Response: Review t he basis f or a hist orical diagnosis of hear t failure.
|
|
What should a person have done fur ther in vestigation?
|
appr opriat
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What should a person have done fur ther in vestigation?. ### Response: appr opriat.
|
|
Chronic hear t failure in adult s: diagnosis and management (NG106) NICE 2023.
|
All
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Chronic hear t failure in adult s: diagnosis and management (NG106) NICE 2023.. ### Response: All.
|
|
What year is NICE 2023?
|
Chronic hear t failure
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What year is NICE 2023?. ### Response: Chronic hear t failure.
|
|
What is the Subject t o Notice of right s?
|
All right s reserved
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the Subject t o Notice of right s?. ### Response: All right s reserved.
|
|
What does VA/DoD CPG f or the Management of Dyslipidemia for Cardiovascular Risk Reduction do?
|
Primary Prevention
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What does VA/DoD CPG f or the Management of Dyslipidemia for Cardiovascular Risk Reduction do?. ### Response: Primary Prevention.
|
|
What is the topic sub-topic # Recommendation Strengtha Pharma cotherapy, Supplements, and Nutraceuticals a. Primary Prevention 6. For primary prevention, we recommend offering what?
|
a moderate -dose statin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the topic sub-topic # Recommendation Strengtha Pharma cotherapy, Supplements, and Nutraceuticals a. Primary Prevention 6. For primary prevention, we recommend offering what?. ### Response: a moderate -dose statin.
|
|
What do we recommend for patients with a >12% 10 -year cardiovascular risk?
|
moderate -dose statin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What do we recommend for patients with a >12% 10 -year cardiovascular risk?. ### Response: moderate -dose statin.
|
|
What is the l ow-density lipoprotein cholesterol >190 mg/dL?
|
moderate -dose statin in patients with a >12% 10 -year cardiovascular risk or l ow-density lipoprotein cholesterol >190 mg/dL or diabetes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the l ow-density lipoprotein cholesterol >190 mg/dL?. ### Response: moderate -dose statin in patients with a >12% 10 -year cardiovascular risk or l ow-density lipoprotein cholesterol >190 mg/dL or diabetes.
|
|
For primary prevention, what do we suggest offering a moderate -dose statin?
|
patients with a >12% 10 -year cardiovascular risk or l ow-density lipoprotein cholesterol >190 mg/dL or diabetes
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: For primary prevention, what do we suggest offering a moderate -dose statin?. ### Response: patients with a >12% 10 -year cardiovascular risk or l ow-density lipoprotein cholesterol >190 mg/dL or diabetes.
|
|
What is the recommended dose of a moderate -dose statin for patients with a 10 -year cardiovascular risk between 6% and 12%?
|
Strong for 7. For primary prevention
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is the recommended dose of a moderate -dose statin for patients with a 10 -year cardiovascular risk between 6% and 12%?. ### Response: Strong for 7. For primary prevention.
|
|
What is a weak for 8?
|
primary prevention in patients on moderate -dose statins
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a weak for 8?. ### Response: primary prevention in patients on moderate -dose statins.
|
|
For primary prevention in patients on moderate dose statins, what do we suggest against?
|
maximizing the statin dose
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: For primary prevention in patients on moderate dose statins, what do we suggest against?. ### Response: maximizing the statin dose.
|
|
Why do we suggest against maximizing the statin dose in patients on moderate -dose statins?
|
lack of evidence proving added cardiovascular benefits and the risks of higher dose statins
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Why do we suggest against maximizing the statin dose in patients on moderate -dose statins?. ### Response: lack of evidence proving added cardiovascular benefits and the risks of higher dose statins.
|
|
What is there insufficient evidence to recommend for or against using for primary prevention?
|
ezetimibe
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is there insufficient evidence to recommend for or against using for primary prevention?. ### Response: ezetimibe.
|
|
What is insufficient evidence to recommend for or against using ezetimibe with or without statins?
|
primar y prevention
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is insufficient evidence to recommend for or against using ezetimibe with or without statins?. ### Response: primar y prevention.
|
|
For primary prevention, we recommend against offering PCSK9 inhibitors due to unknown long-term safety, inconclusive evidence for benefit, and high cost?
|
10
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: For primary prevention, we recommend against offering PCSK9 inhibitors due to unknown long-term safety, inconclusive evidence for benefit, and high cost?. ### Response: 10.
|
|
Evidence for benefit and high cost?
|
inconc lusive
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: Evidence for benefit and high cost?. ### Response: inconc lusive.
|
|
For secondary prevention, what do we recommend using at least a moderate-dose statin?
|
Strong for 12
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: For secondary prevention, what do we recommend using at least a moderate-dose statin?. ### Response: Strong for 12.
|
|
What do we suggest for patients who are willing to intensify treatment?
|
offering high -dose statins
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What do we suggest for patients who are willing to intensify treatment?. ### Response: offering high -dose statins.
|
|
What are high -dose statins supposed to reduce?
|
non -fatal cardiovascular events
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What are high -dose statins supposed to reduce?. ### Response: non -fatal cardiovascular events.
|
|
What is ezetimibe used for in higher risk patients who are willing to intensify treatment?
|
secondary prevention
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is ezetimibe used for in higher risk patients who are willing to intensify treatment?. ### Response: secondary prevention.
|
|
What do we suggest adding to statins for reducing non -fatal cardiovascular events?
|
ezetimibe
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What do we suggest adding to statins for reducing non -fatal cardiovascular events?. ### Response: ezetimibe.
|
|
What do we suggest for secondary prevention in higher risk patients who are willing to intensify treatment?
|
offering high -dose statins
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What do we suggest for secondary prevention in higher risk patients who are willing to intensify treatment?. ### Response: offering high -dose statins.
|
|
What is a PCSK9 inhibitor in addition to?
|
a maximally tolerated statin dose
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a PCSK9 inhibitor in addition to?. ### Response: a maximally tolerated statin dose.
|
|
What is a PCSK9 inhibitor in addition to a maximally tolerated statin dose with ezetimibe for reducing non -fatal cardiovascular events?
|
For secondary prevention
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is a PCSK9 inhibitor in addition to a maximally tolerated statin dose with ezetimibe for reducing non -fatal cardiovascular events?. ### Response: For secondary prevention.
|
|
A discussion of their uncertain long -term safety, additional benefits, and an exploration of the patient’s values and preferences are what?
|
risk of high -dose statins
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: A discussion of their uncertain long -term safety, additional benefits, and an exploration of the patient’s values and preferences are what?. ### Response: risk of high -dose statins.
|
|
What is weak for c. Other Medications, Supplements, and Nutraceuticals?
|
15
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: What is weak for c. Other Medications, Supplements, and Nutraceuticals?. ### Response: 15.
|
|
For primary or secondary prevention, what do we recommend against using?
|
niacin
|
Below is an instruction that describes a task. Write a response that appropriately completes the request. ### Instruction: For primary or secondary prevention, what do we recommend against using?. ### Response: niacin.
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.